2-Hydroxyglutaricaciduria: Clinical Trials

1 trial for 2-Hydroxyglutaricaciduria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. .

Follow 2-Hydroxyglutaricaciduria: new trials by email Literature Review of 2-Hydroxyglutaricaciduria trials Research Report on 2-Hydroxyglutaricaciduria

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
collection of data - Inherited Disease, Rare Diseases
RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1002021-03-012024-11-19

Narrower conditions

Adrenoleukodystrophy (1)  ·  Alexander Disease (1)  ·  Cysts (1)  ·  Fahr's disease (1)  ·  Genetic Diseases, Inborn (1)  ·  Hepatolenticular Degeneration (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Leukoencephalopathies (1)  ·  Metabolic Diseases (1)  ·  Methylmalonic acidemia with homocystinuria (1)  ·  Nervous System Diseases (1)  ·  Pelizaeus-Merzbacher Disease (1)  ·  Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (1)

Broader conditions

Adrenal Gland Diseases (1)  ·  Adrenal Insufficiency (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Demyelinating Diseases (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Genetic Diseases, X-Linked (1)  ·  Hereditary Central Nervous System Demyelinating Diseases (1)  ·  Heredodegenerative Disorders, Nervous System (1)

Sponsors

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)

Countries

Italy (1)

Results publications

PMID 37782421, PMID 41667276